Cord blood clues: scientists hunt for HHT treatment targets
NCT ID NCT05632484
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 30 times
Summary
This study looked at cells from the umbilical cords of 16 newborns who had a parent with hereditary hemorrhagic telangiectasia (HHT), a rare disorder that causes abnormal blood vessels and bleeding. Researchers grew these cells in the lab to compare their genes with cells from healthy babies. The goal was to find new targets for future treatments. This was a basic science study, not a treatment trial, so there was no direct benefit to participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY HAEMORRHAGIC TELANGIECTASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Estaing
Clermont-Ferrand, 63100, France
-
Hôpital Femme-mère-Enfant
Bron, 69677, France
-
Hôpital St Eloi
Montpellier, 34295, France
Conditions
Explore the condition pages connected to this study.